Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

21 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-02-13

Study Completion Date

2021-02-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal cancer.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer

NCT00531297

Rectal Neoplasms

TERMINATED NA

Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer

NCT00910143

Rectal Cancer

COMPLETED

Long-term Cohort Study of Mesorectal Excision for Rectal Cancer

NCT05112016

Rectum Cancer

RECRUITING

Pelvic Drain After Rectal Resection for Mid-low Rectal Cancer

NCT04573621

Rectal Cancer

UNKNOWN NA

Five Year Oncological Outcome After CME for Right-sided Colon Cancer

NCT03754075

Colonic Neoplasms

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Twenty patients undergoing taTME for rectal cancer is included. Following the closure of the rectal lumen by a purse string suture, rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity. Each sample is cytologically examined by a pathologist and labelled either malignant or non-malignant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing rectal washout in transanal mesorectal excision

Patients undergoing rectal washout in transanal mesorectal excision for rectal cancer.

Rectal washout

Intervention Type PROCEDURE

Rectal washout is performed intraoperatively before transection and means irrigation of the rectum following the closure of the rectal lumen below the tumour with a purse string suture. Rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rectal washout

Rectal washout is performed intraoperatively before transection and means irrigation of the rectum following the closure of the rectal lumen below the tumour with a purse string suture. Rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity.

Intervention Type PROCEDURE